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OBJECTIVE—Although advanced age is a risk factor for type 2
diabetes, a clear understanding of the changes that occur during
middle age that contribute to the development of skeletal muscle
insulin resistance is currently lacking. Therefore, we sought to
investigate how middle age impacts skeletal muscle fatty acid
handling and to determine how this contributes to the develop-
ment of diet-induced insulin resistance.
RESEARCH DESIGN AND METHODS—Whole-body and skel-
etal muscle insulin resistance were studied in young and middle-
aged wild-type and CD36 knockout (KO) mice fed either a
standard or a high-fat diet for 12 weeks. Molecular signaling
pathways, intramuscular triglycerides accumulation, and tar-
geted metabolomics of in vivo mitochondrial substrate ﬂux were
also analyzed in the skeletal muscle of mice of all ages.
RESULTS—Middle-aged mice fed a standard diet demonstrated
an increase in intramuscular triglycerides without a concomitant
increase in insulin resistance. However, middle-aged mice fed a
high-fat diet were more susceptible to the development of insulin
resistance—a condition that could be prevented by limiting
skeletal muscle fatty acid transport and excessive lipid accumu-
lation in middle-aged CD36 KO mice.
CONCLUSION—Our data provide insight into the mechanisms
by which aging becomes a risk factor for the development of
insulin resistance. Our data also demonstrate that limiting skel-
etal muscle fatty acid transport is an effective approach for
delaying the development of age-associated insulin resistance
and metabolic disease during exposure to a high-fat diet.
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O
ver the past few decades, type 2 diabetes has
increased in prevalence largely as a result of
the obesity epidemic (1). Although it is widely
accepted that skeletal muscle insulin resistance
is a major determinant in both the onset and progression
of type 2 diabetes (2), the exact cause of decreased insulin
action in skeletal muscle is not known (3). That said, it is
generally believed that skeletal muscle insulin resistance
develops secondary to impaired mitochondrial fatty acid
oxidation (4,5). However, several other studies have
shown that lipid accumulation is not associated with
skeletal muscle insulin resistance (6–8) or overall mito-
chondrial dysfunction (9–13). Consistent with this, a grow-
ing body of evidence has suggested that the cause of
skeletal muscle insulin resistance may not result from
impaired fatty acid oxidation but might actually result
from excessive skeletal muscle mitochondrial fatty acid
oxidation and ensuing mitochondrial stress (12,14). While
it is not known which of these two processes are most
relevant in the pathogenesis of skeletal muscle insulin
resistance, it is clear that excessive entry of fatty acids into
the skeletal muscle plays a central role in diet-induced
insulin resistance.
Because advanced age is a signiﬁcant risk factor in the
etiology of type 2 diabetes (15,16), the accompanying loss
of mitochondrial function observed with normal aging has
been proposed to contribute to the increased risk of type
2 diabetes in the elderly population (17). However, a clear
understanding of the physiological changes that occur
during the onset of middle age and the inﬂuence that this
may have on the development of insulin resistance is
currently lacking. This is particularly important given that
the baby boomer generation, the largest population group
in the Western world, is currently classiﬁed as middle-aged
(18) as well as the fact that the prevalence of type 2
diabetes in the Western world is expected to increase
dramatically over the next 5–10 years (16,18). The study
herein was designed to investigate how middle age im-
pacts whole-body glucose utilization, fatty acid handling,
and triglyceride accumulation within skeletal muscle as
well as the susceptibility of middle-aged mice to the
development of diet-induced insulin resistance.
RESEARCH DESIGN AND METHODS
Reagents. Antibodies against AMP kinase (AMPK), phosporylated AMPK
(pAMPK), acetyl CoA carboxylase (ACC), phosporylated ACC, Akt, phospory-
lated Akt, and tubulin were from Cell Signaling; anti-Oxphos was from
MitoSciences; anti–CD36-[HRP] was purchased from NOVUS Biologicals, and
human recombinant insulin (Novolin) from Novo Nordisk Canada.
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Animal Policy and Welfare Committee. Experiments were carried out on male
wild-type (C57BL6) and CD36 knockout (KO) mice (19) maintained in a
temperature-controlled room with a reversed 12-h light/12-h dark cycle. Mice
were left relatively undisturbed for either 12–14 or 52–58 weeks of age with
free access to water and standard rodent diet (category no. 5001; LabDiet). At
32–34 weeks of age, a subset of mice was randomly divided into a low-fat diet
group (category no. D12450B; Research Diets) and a high-fat diet group
(category no. D12492; Research Diets) for a period of 12 weeks.
Metabolic analysis in vivo. Indirect calorimetry was performed using the
Comprehensive Lab Animal Monitoring System (Oxymax/CLAMS; Columbus
Instruments, Colombus, OH). Following an initial 24-h acclimatization period,
mice were monitored every 13 min for 24 h to complete a 12-h dark
(active)/12-h light (inactive) cycle. The respiratory exchange ratio (RER 
VCO2/VO2) was used to estimate the percent contribution of fat and carbohy-
drate to whole-body energy metabolism in mice in vivo. Total activity was
calculated by adding Z counts (rearing or jumping) to total counts associated
with ambulatory movement and stereotypical behavior (grooming and
scratching).
Determination of skeletal muscle triglycerides, long-chain acyl-CoA,
and ceramides. Upon phospholipid digestion with phospholipase C (2 h at
30°C) and lipid extraction, levels of triglycerides were determined in gastroc-
nemius muscle lysates by gas-liquid chromatography as previously described
(20). Identiﬁcation and quantiﬁcation of the major long-chain acyl-CoA
molecular species (C16:0, C18:0, and C18:1) and C18-ceramides were per-
formed by high-performance liquid chromatography as previously described
(21).
Metabolic proﬁling. Overnight-fasted mice were anesthetized with sodium
pentobarbital, and gastrocnemius muscle was rapidly removed and freeze-
clamped in liquid nitrogen and stored at 80°C. Sample preparation was
performed as previously described (14). Acylcarnitine measurements were
made using ﬂow-injection tandem mass spectrometry as previously described
(14), and organic acids were quantiﬁed as previously described (22).
Statistical analysis. Data are expressed as means  SEM. Comparisons
between groups were performed using unpaired Student’s two-tailed t test or
ANOVA with a Bonferroni post hoc test of pairwise comparisons where
appropriate. A probability value of 0.05 is considered signiﬁcant. For further
descriptions of the materials and methods, refer to the supplementary
material available in an online appendix, available at http://diabetes.
diabetesjournals.org/cgi/content/full/db09-1142/DC1.
RESULTS
Age-induced slowing of metabolic rate increases sus-
ceptibility to metabolic disease. To determine whether
an age-related decline in resting metabolic rate and energy
expenditure might contribute to the development of insu-
lin resistance, C57Bl6 mice of 12–14 (young) or 52–58
(middle-aged) weeks of age were analyzed using indirect
calorimetry. As mice aged and body weight was increased
(Fig. 1A), substrate use was altered slightly, with reduc-
tions in RER indicating that middle-aged mice used more
fatty acid throughout the day compared with young mice
(Fig. 1B). In addition, signiﬁcant reductions in oxygen
consumption (VO2) (Fig. 1C) and carbon dioxide produc-
tion (VCO2) (Fig. 1D) were observed during both the dark
(active) and light (inactive) phases in middle-aged mice
compared with young mice. Consistent with this, heat
production (Fig. 1E) was decreased in middle-aged mice
compared with young mice, whereas activity measure-
ments were not signiﬁcantly different between age-groups
(Fig. 1F). Taken together, our data indicate that middle-
aged mice have a lower metabolic rate than young mice
and that this might increase susceptibility to weight gain,
obesity, and metabolic disease.
Age-induced alterations in fatty acid handling and
lipid accumulation in skeletal muscle precede the
development of whole-body glucose intolerance.
Given that skeletal muscle metabolism contributes to
whole-body basal metabolic rate, we addressed whether
skeletal muscle metabolism was depressed in middle-aged
mice by assessing the activities of two enzymes involved in
regulating mitochondrial metabolism. Interestingly, the
activity of -hydroxyacyl–CoA dehydrogenase (-HAD)
(Fig. 2A) was elevated in the middle-aged compared with
the young mice, and citrate synthase (Fig. 2B) followed a
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FIG. 1. Depressed metabolic rate in middle-aged mice fed a standard laboratory diet. Body weight of young (12–14 weeks of age) and middle-aged
(52–58 weeks of age) mice fed a standard laboratory diet (A). Indirect calorimetry was performed to measure respiratory exchange ratio (RER)
(B), VO2 (C), VCO2 (D), and heat production adjusted for bodyweight (E); total activity (F) was measured in both the dark (active) and light
(inactive) phases. Values are means  SEM of n  5–7 mice in each group. *P < 0.05 indicates comparisons performed between young and
middle-aged mice in either dark or light phases (Mann-Whitney U Test). Two-way ANOVA was performed for RER (B) and indicated the main
effect for age (P < 0.01).
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cycle activity were not directly compromised in the mid-
dle-aged mice. Since mitochondrial number (Fig. 2C)o r
function did not appear to be altered at middle age, we
next assessed whether peroxisome proliferator–activated
receptor (PPAR) responsive genes or molecular signaling
cascades known to regulate skeletal muscle fatty acid ﬂux
and fatty acid entry into the mitochondria were associated
with this overall reduction in whole-body basal metabolic
rate observed in middle age. Although a more comprehen-
sive assessment of the multiple mediators of fatty acid
utilization may reveal additional mechanisms, we did not
observe any changes in protein levels of known PPAR
responsive genes involved in lipid metabolism, including
malonyl-CoA decarboxylase and acyl-CoA synthetase 1
(data not shown). As a result, we also examined the
energy-sensing kinase, AMPK, which is known for its
ability to govern energy metabolism (23). In agreement
with previous reports using older rodents (24,25), levels of
phosphorylated AMPK were signiﬁcantly reduced in skel-
etal muscle of middle-aged mice compared with young
mice (Fig. 2D), whereas total AMPK levels remained
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FIG. 2. Alterations in fatty acid handling and reduced insulin signaling in skeletal muscle of middle-aged mice do not result in impaired
whole-body glucose tolerance. Activity of two mitochondrial enzymes -HAD (A) and citrate synthase (CS) (B) was determined in gastrocnemius
muscle from overnight fasted young (12–14 weeks of age) and middle-aged (52–58 weeks of age) mice. Immunoblot analysis using a total OXPHOS
complex antibody cocktail was performed in gastrocnemius muscle lysates, and immunoblots were normalized against tubulin as a control for
protein loading (C). Phosphorylation status of AMPK at threonine 172 (D) and ACC at serine 79 (F) was detected using immunoblot analysis with
phospho-speciﬁc antibodies. Immunoblots were quantiﬁed by densitometry and normalized against total protein levels of AMPK (E) and ACC
(F). Triglyceride (TG) levels (G) and phosphorylation status of Akt (H) were determined in gastrocnemius muscle from overnight-fasted young
and middle-aged mice. Gastrocnemius muscle was collected from a separate group of overnight-fasted young and middle-aged mice following
intraperitoneal injection with either saline or human recombinant insulin (10 units/kg), and immunoblots were performed to detect
phosphorylation status of Akt at serine 473 in gastrocnemius muscle lysates (I). Glucose tolerance test (J) was performed in young () and
middle-aged (f) mice following a 6-h fast. Serum insulin was detected in young and middle-aged mice after an overnight fast (K). Values are
means  SEM of n  5–7 mice in each group. *P < 0.05 indicates comparisons performed between young and middle-aged mice (Mann-Whitney
U Test).
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tus of acetyl CoA carboxylase (ACC), the downstream
target of AMPK that indirectly regulates fatty acid entry
into the mitochondria and ultimately -oxidation, was
signiﬁcantly decreased in skeletal muscle from middle-
aged mice (Fig. 2F). Although reduced AMPK phosphory-
lation could be the result of impaired activity of upstream
AMPK kinases or increased AMPK phosphatase activity, it
is currently unknown which of these contributes to re-
duced AMPK phosphorylation in our model. However,
consistent with decreased energy expenditure, increased
adiposity, and reduced AMPK activity in skeletal muscle
from middle-aged mice, the levels of skeletal muscle
triglycerides were signiﬁcantly elevated in middle-aged
mice compared with young mice (Fig. 2G). Given that lipid
accumulation in skeletal muscle has been proposed in
rodents (26) and humans (17,27,28) to be one of the
primary causes of skeletal muscle insulin resistance, we
next investigated whether glucose tolerance was im-
paired in middle-aged mice. Despite elevated intramus-
cular triglycerides (Fig. 2G) and impaired basal and
insulin-stimulated Akt phosphorylation (Fig. 2H and I,
respectively) in skeletal muscle of middle-aged mice,
whole-body glucose tolerance (Fig. 2J) and fasted insulin
levels (Fig. 2K) were not different in middle-aged com-
pared with young mice, suggesting that age-induced alter-
ations in skeletal muscle fatty acid handling and increased
triglyceride storage precede the development of insulin
resistance and metabolic disease.
Aging increases the sensitivity to diet-induced obe-
sity and metabolic disease. Since we speculated that
middle-aged mice are more susceptible than young mice to
the development of insulin resistance, young and middle-
aged mice were subjected to high-fat feeding for 12 weeks.
Although young mice fed a high-fat diet displayed weight
gain (Fig. 3A) and signs of glucose intolerance compared
with young mice fed a low-fat diet (Fig. 3B, C, and I), Akt
phosphorylation (Fig. 3D) and insulin levels (Fig. 3E and
F) remained relatively normal in these mice. In contrast,
middle-aged mice fed a high-fat diet showed signiﬁcant
weight gain (body weight: low fat, 30.18  0.70 g, high fat,
55.14  1.56 g; P  0.05) and displayed dramatically
elevated insulin levels (Fig. 3E and F), whereas blood
glucose levels remained stable (Fig. 3G). In addition,
whole-body glucose tolerance in the middle-aged mice fed
a high-fat diet was signiﬁcantly impaired compared with
that in middle-aged mice fed a low-fat diet (Fig. 3H and I).
Although activation of insulin signaling, as determined by
the phosphorylation status of Akt is not impaired in
skeletal muscle of young (Fig. 3D) or middle-aged (Fig. 3J)
mice fed a high-fat diet compared with that in mice fed a
low-fat diet, this is likely due to elevated levels of circu-
lating insulin (Fig. 3E and F) observed in the respective
high-fat groups. In support of the glucose tolerance data,
homeostasis model assessment of insulin resistance val-
ues were signiﬁcantly higher in the high-fat–fed middle-
aged mice (Fig. 3K), suggesting that high-fat feeding
induces more dramatic insulin resistance in middle-aged
mice than in young mice. Interestingly, young mice on a
high-fat diet were of the same weight as middle-aged mice
on a low-fat diet; yet, only the young mice on a high-fat diet
had impaired glucose disposal (data not shown). Although
we cannot discriminate between the effects of aging and
increased adiposity because these variables coassociate,
our ﬁndings do suggest that the increased weight gain
associated with aging is not sufﬁcient to alter whole-body
glucose disposal and that other factors such as high-fat
diet are likely involved.
Because high-fat diet–induced insulin resistance in
young rodents is associated with an increased efﬁciency of
fatty acid uptake into skeletal muscle (26), protein expres-
sion of CD36, a protein that facilitates fatty acid transport,
was determined in skeletal muscle of mice fed a high-fat
diet. Consistent with previous publications in young mice
(26,29,30), we observed a modest increase in CD36 protein
expression in the muscle of young mice fed a high-fat diet,
as well as an increase in intramuscular triglyceride levels
(data not shown). Consistent with our hypothesis, CD36
expression was signiﬁcantly elevated in skeletal muscle of
middle-aged mice fed a high-fat diet compared with that in
mice fed a low-fat diet (Fig. 3L). In accordance with
increased CD36 protein expression, skeletal muscle tri-
glyceride levels were signiﬁcantly elevated in high-fat–fed
middle-aged mice compared with those in low-fat–fed
mice (Fig. 3M), as were long-chain acyl-CoA esters (Fig.
3N) and ceramides (Fig. 3O). Together, these data suggest
that increased CD36-mediated fatty acid transport may
contribute to lipid accumulation and impaired insulin
sensitivity in skeletal muscle of middle-aged mice fed a
high-fat diet.
Ablation of CD36 protects against diet-induced obe-
sity in middle-aged mice. To investigate whether inhibi-
tion of fatty acid transport into the skeletal muscle could
alter the observed responses of a middle-aged mouse to a
high-fat diet, we utilized the CD36 KO mouse, which has
skeletal muscle fatty acid uptake rates 40–70% of those
in wild-type mice (31,32). Interestingly, there was a strik-
ing difference in weight gain between middle-aged wild-
type and CD36 KO mice following 12 weeks of high-fat
feeding (Fig. 4A), with middle-aged CD36 KO mice accu-
mulating 51% less weight than the wild-type mice over the
same period of time (Fig. 4B). Though differences in
caloric intake (Fig. 4C) or substrate preference (Fig. 4D)
between groups could not account for this dramatic
change in weight gain, indirect calorimetry indicated that
energy expenditure (Fig. 4E and F) and overall activity
(Fig. 4G) were signiﬁcantly increased in middle-aged CD36
KO mice fed a high-fat diet compared with those in
high-fat–fed middle-aged wild-type mice. Although this
increased activity in the middle-aged CD36 KO mouse fed
a high-fat diet could be attributed to the absence of
obesity, heat production was also increased in middle-
aged CD36 KO mice fed a low-fat diet compared with that
in low-fat–fed middle-aged wild-type mice (Fig. 4H) and in
high-fat–fed middle-aged KO mice when normalized for
body weight (Fig. 4I).
Alterations in muscle metabolites and lipid balance
correspond with protection against diet-induced in-
sulin resistance. To gain a more comprehensive meta-
bolic assessment of muscle metabolism in middle-aged
wild-type and CD36 KO mice fed a low-fat or high-fat diet,
we used mass spectrometry to measure a broad range of
intermediary metabolites, including acylcarnitines of var-
ious chain lengths, organic acids, and amino acids. Acyl-
carnitines are by-products of fuel catabolism that respond
to changes in substrate availability or ﬂux limitations at
speciﬁc mitochondrial enzymes (14,33,34). Middle-aged
CD36 KO mice fed a low-fat diet had elevated levels of
acetyl-carnitine (C2), and -hydroxybutyryl-carnitine (C4OH)
compared with their wild-type counterparts (supplemental
Fig. 1A and supplemental Table 1). Whereas several short-
chain acylcarnitine species, including C2 and C4OH, as
D.P.Y. KOONEN AND ASSOCIATES
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(C4DC), tended to increase in response to a high-fat diet,
these same metabolites trended downward in CD36 KO
mice fed a high-fat diet (supplemental Fig. 1A and supple-
mental Table 1).
In addition, several long-chain acylcarnitine species
were reduced in muscle from wild-type mice fed a high-fat
diet while at the same time levels of hydroxylated long-
chain acylcarnitine (LCOH) species were increased, result-
ing in a robust increase in the long-chain–to–LCOH
acylcarnitine ratio (Fig. 5A–C). Given that long-chain
acylcarnitines accumulate when their production by mito-
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FIG. 3. Aging increases the susceptibility to the development of glucose intolerance and insulin resistance in mice fed a high-fat diet. Body weights
(A), fed and fasted blood glucose (B), glucose tolerance test (C), and phosphorylation status of Akt (D) were measured in gastrocnemius muscle
from young (12–14 weeks of age) mice following 12 weeks of high fat (HF) feeding. Serum insulin levels in the fasted (E) and fed (F) states
obtained from young (12–14 weeks of age) and middle-aged (48–52 weeks of age) mice fed a low-fat (LF) and high-fat diet for 12 weeks. Fed and
fasted blood glucose levels (G), glucose tolerance test (H), area under the curve (AUC) for the glucose tolerance test (I), and phosphorylation
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resistance (HOMA-IR) as a surrogate marker of insulin resistance in young and middle-aged mice fed a high-fat diet (K). Immunoblot analysis
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were quantiﬁed by densitometry and normalized against tubulin as a control for protein loading (L). Triglyceride (TG) (M), long-chain acyl-CoA
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are means  SEM of n  8 mice in each group. Two-way ANOVA was performed to detect main effects of age, diet, and age  diet interactions
on insulin levels (E and F) and HOMA-IR (K). Signiﬁcant effect of age, diet, and age  diet interaction (P < 0.05) was observed for E, F, and K.
*P < 0.05 indicates comparisons performed between young and middle-aged mice or between low- and high-fat fed mice in fed or fasted state
(Mann-Whitney U Test).
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ﬂux through -oxidation enzymes, such as long-chain
acyl-CoA dehydrogenase (LCAD) and -HAD (35), this
pattern is consistent with a diet-induced shift in ﬂux
limitation from LCAD to -HAD. Notably, levels of many
long-chain and LCOH acylcarnitines were lower in the
CD36 KO mice fed a high-fat diet than in the wild-type
mice fed a high-fat diet (Fig. 5A; supplemental Table 1).
The organic acids were less responsive to both diet and
genotype, although subtle changes were detected in suc-
cinate, fumarate, and citrate levels (supplemental Fig. 1B
and C; supplemental Table 2). Muscle levels of amino acids
were higher in wild-type mice fed a low-fat diet but were
dramatically decreased following high-fat feeding. By com-
parison, amino acid levels remained unchanged in CD36
KO mice in response to a high-fat diet (supplemental Fig.
1D; supplemental Table 2). Although these metabolite
measurements do not fully characterize mitochondrial
substrate ﬂux, together the data suggest that ablation of
CD36 not only alters baseline mitochondrial and interme-
diary metabolism but also signiﬁcantly impacts the muscle
response to lipid exposure.
Ablation of CD36 and reduction in intramuscular
lipid accumulation prevent the development of diet-
induced insulin resistance. Interestingly, despite the
changes in muscle acylcarnitine levels, the activity of
-HAD was not altered (data not shown) and middle-aged
CD36 KO mice fed a high-fat diet were not protected from
decreased levels of AMPK or ACC phosphorylation (Fig.
5D and E) compared with young wild-type mice (Fig. 2D
and F), suggesting that alternate mechanisms are respon-
sible for the metabolic phenotype observed in CD36 KO
mice. Similarly, absolute expression of AMPK and ACC in
skeletal muscle from aged CD36 mice is not different
between groups (data not shown). Although serum free
fatty acid levels were elevated in high-fat–fed CD36 KO
mice (Fig. 5F), CD36 ablation resulted in a signiﬁcant
reduction in skeletal muscle triglycerides (Fig. 5G) and
long-chain acyl-CoA’s (Fig. 5H) accumulation. By contrast,
ceramide levels remained similar between high-fat fed
groups (Fig. 5I), suggesting that accumulation of lipid-
derived intermediates other than ceramides, may contrib-
ute to impaired insulin sensitivity. Indeed, reduced
intramuscular lipid accumulation in middle-aged CD36 KO
0
1000
2000
3000
4000
5000
LF HF LF HF
Dark Light
*
*
V
O
2
(
m
l
/
k
g
/
h
r
)
0.0
0.2
0.4
0.6
0.8
1.0
LF HF LF HF
*
* *
Dark Light
H
e
a
t
 
P
r
o
d
u
c
t
i
o
n
(
k
c
a
l
/
h
r
)
WT CD36 KO
LF HF
0
5
10
15
20
25
30
*
*
W
e
i
g
h
t
 
G
a
i
n
(
g
)
LF HF
0.0
0.1
0.2
0.3
0.4
0.5
0.6
F
o
o
d
 
I
n
t
a
k
e
 
2
4
 
h
r
(
k
c
a
l
/
g
 
B
W
)
0
1000
2000
3000
4000
5000
*
*
T
o
t
a
l
 
A
c
t
i
v
i
t
y
(
c
o
u
n
t
s
)
0.65
0.67
0.69
0.71
0.73
0.75
8 AM 12 PM 4 PM 8 PM 12 AM
WT HF KO HF
4 AM
R
E
R
(
V
C
O
2
/
V
O
2
)
0
5
10
15
20
25
LF HF LF HF
*
*
*
Dark Light
H
e
a
t
 
P
r
o
d
u
c
t
i
o
n
(
k
c
a
l
/
k
g
/
h
r
)
0
1000
2000
3000
4000
LF HF LF HF
LF HF
*
*
Dark Light
V
C
O
2
(
m
l
/
k
g
/
h
r
)
AC
H I
B
F
D
E G
FIG. 4. Protection of diet-induced obesity in middle-aged CD36 KO mice fed a high-fat (HF) diet for 12 weeks. Representative image of
middle-aged (48–52 weeks of age) wild-type () and CD36 KO (f) mice fed a high-fat diet for 12 weeks (A). Weight gain (B) and food intake
adjusted for body weight (BW) (C) in wild-type and KO mice fed a high-fat diet. Respiratory exchange ratio (RER) (D), oxygen consumption
(VO2)( E), and carbon dioxide production (VCO2)( F) in both the dark (active) and light (inactive) phase following 12 weeks of high-fat feeding
in wild-type and KO mice. Total activity for a complete dark/light cycle (G), heat production (H), and heat production adjusted for body weight
(I) in wild-type and KO mice following 12 weeks of high-fat feeding. Values are the means  SEM of n  6–10 mice in each group. *P < 0.05
indicates comparisons performed between the low-fat (LF)-fed mice and between high-fat–fed mice (Mann-Whitney U test [B and G] or ANOVA
with Bonferroni post hoc test for pairwise comparison). (A high-quality digital representation of this ﬁgure is available in the online issue.)
D.P.Y. KOONEN AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, JUNE 2010 1371C12
C14:1
C14
C16:1
C16
C18:1
C18
C20
C8:1-OH
C8:1-DC
C10-OH
C12-OH
C14:1-OH
C14-OH
C16:1-OH
C16-OH
C18:1-OH
C18-OH
0
5
10
15
20
** **
** **
**
**
** **
**
**
**
**
**
A
c
y
l
c
a
r
n
i
t
i
n
e
s
-
M
C
 
&
 
L
C
(
p
m
o
l
/
m
g
 
p
r
o
t
e
i
n
)
Sum LC Sum LC-OH
0
20
40
60
80 WT LF
WT HF
KO LF
KO HF
WT LF
WT HF
KO LF
KO HF
A
c
y
l
c
a
r
n
i
t
i
n
e
s
(
p
m
o
l
/
m
g
 
p
r
o
t
e
i
n
)
0.0
0.2
0.4
0.6
0.8
1.0
WT-HF KO-HF
S
e
r
u
m
 
F
F
A
(
m
m
o
l
/
L
)
0
1
2
3
**
WT
LF HF
KO
LF HF
p-ACC
ACC
WT
LF
KO WT
HF
KO
S
u
m
 
o
f
 
L
C
-
O
H
/
S
u
m
 
L
C
0
25
50
75
WT-HF KO-HF
M
u
s
c
l
e
 
T
G
(
µ
g
/
m
g
 
p
r
o
t
e
i
n
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
*
WT
KO
p
A
M
P
K
/
A
M
P
K
(
r
e
l
a
t
i
v
e
 
t
o
 
W
T
 
L
F
)
0
1
2
3
WT-HF KO-HF
* *
L
C
C
o
A
(
p
m
o
l
/
m
g
 
w
w
)
LF HF LF HF
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
*
WT
KO
p
A
C
C
/
A
C
C
(
r
e
l
a
t
i
v
e
 
t
o
 
W
T
 
L
F
)
0
20
40
60
80
100
WT-HF KO-HF
C
e
r
a
m
i
d
e
(
p
m
o
l
/
m
g
 
w
w
)
0
2
4
6
8
10
WT-HF KO-HF
B
l
o
o
d
 
G
l
u
c
o
s
e
(
m
m
o
l
/
L
)
0.0
0.5
1.0
1.5
2.0
WT-HF KO-HF
** **
*
* *
S
e
r
u
m
 
I
n
s
u
l
i
n
-
F
a
s
t
e
d
(
n
g
/
d
l
)
0 30 60 90 120
40
60
80
100
WT-HF KO-HF
WT-HF KO-HF
* * * *
*
Time (min)
B
l
o
o
d
 
G
l
u
c
o
s
e
(
%
 
i
n
i
t
i
a
l
 
a
t
 
t
=
0
)
LF HF
0.0
0.2
0.4
0.6
0.8
1.0 WT
KO
p
A
K
T
/
A
K
T
(
r
e
l
a
t
i
v
e
 
t
o
 
W
T
 
L
F
)
A
E D
H
K M
0 30 60 90 120
0
10
20
30
40
*
*
*
Time (min)
B
l
o
o
d
 
G
l
u
c
o
s
e
(
m
m
o
l
/
L
)
p-AKT
AKT
WT
LF
KO WT
HF
KO
p-AMPK
AMPK
WT
LF
KO WT
HF
KO B C
F G I J
L N
FIG. 5. Altered skeletal muscle lipid handling prevents development of insulin resistance in middle-aged CD36 KO mice fed a high-fat (HF) diet
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glucose tolerance (Fig. 5J) and signiﬁcantly lower fasting
blood glucose levels (Fig. 5K) compared to high-fat fed
middle-aged wild-type mice. Moreover, fasted insulin lev-
els were signiﬁcantly reduced (Fig. 5L) and insulin-in-
duced glucose clearance was dramatically improved (Fig.
5M) in high-fat fed middle-aged CD36 KO mice compared
to high-fat fed middle-aged wild-type mice, suggesting that
insulin sensitivity is restored by preventing lipid accumu-
lation in skeletal muscle. Interestingly, despite improved
glucose utilization and reduced plasma insulin levels in
these mice, the phosphorylation status of Akt was similar
in skeletal muscle from middle-aged wild-type and CD36
KO mice on high-fat diet (Fig. 5N). Furthermore, we found
no difference in glycogen content in livers from CD36 KO
mice fed a low-fat or high-fat diet (data not shown),
suggesting that the improved glucose tolerance observed
in these mice is the result of increased glucose uptake
and/or glucose oxidation in skeletal muscle from CD36 KO
mice and not alterations in hepatic glucose metabolism.
DISCUSSION
Consistent with previous reports (17), our data show a
signiﬁcant decline in metabolic rate in middle-aged mice
when compared to their young counterparts (Fig. 1B–1F).
Interestingly, although mitochondrial function was not
directly assessed in this study, the decline in overall
metabolic rate did not appear to stem from compromised
mitochondrial function in skeletal muscle of middle-aged
mice compared to young mice. Indeed, whole body RER
was modestly decreased with aging and muscle activity of
-HAD increased, suggesting there is a shift in substrate
selection from carbohydrates toward fatty acids. However,
the age-associated reduction in overall metabolic rate did
not appear to correlate with changes in maximal activities
of mitochondrial enzymes in muscle from young and
middle-aged mice (Fig. 2A and 2B), suggesting other
factors may inﬂuence substrate oxidation in muscle, as
well as overall metabolic rate. Consistent with this, the
AMPK/ACC signaling axis was signiﬁcantly reduced in
skeletal muscle from middle-aged mice (Fig. 2D and 2F).
Still unclear is whether reduced AMPK phosphorylation in
the older mice reﬂects a cause or consequence of reduced
metabolic rate. Although results of a recent study suggest
that ACC-mediated shifts in fat oxidation per se do not
impact whole body energy expenditure or susceptibility to
diet-induced obesity (36), AMPK acts on a broad range of
enzymatic and transcriptional targets that could affect
energy balance via mechanisms other than substrate se-
lection (25,37). Nonetheless, CD36 deﬁciency raised met-
abolic rate without activating AMPK, indicating that other
mechanisms are operative in this model (see below).
Although Akt phosphorylation is reduced in skeletal
muscle from middle-aged mice compared to young mice
(Fig. 2H and 2I) whole-body glucose tolerance and plasma
insulin levels remained normal (Fig. 2J and 2K), suggesting
that impaired activation of insulin-signaling parameters in
skeletal muscle precede overt changes in whole body
glucose disposal and may increase the susceptibility of
aged mice to diet-induced insulin resistance. To determine
whether middle-aged mice indeed are more susceptible to
developing insulin resistance in response to a high-fat diet
compared to their younger counterparts, we subjected
middle-aged mice to 12 weeks of a low-fat or high-fat diet.
As expected, middle-aged mice gained signiﬁcantly more
weight than young mice when fed a high-fat diet (weight
gain: middle-aged, 22.8  1.9 g versus young, 12.0  1.1 g;
P  0.01). Although impairment of glucose tolerance was
similar between age-groups (Fig. 3C, 3H and 3I), high-fat
diet-induced hyperinsulinemia was only observed in mid-
dle-aged mice (Fig. 3E and 3F), indicating that increased
-cell insulin secretion was sufﬁcient to offset overt hyper-
glycemia in this age-group (Fig. 3G). Given that prolonged
hypersecretion of insulin by the -cells to compensate for
peripheral insulin resistance can contribute to -cell fail-
ure (38) and potentially type 2 diabetes (39), our data
suggest that middle-aged mice have a heightened suscep-
tibility to the development of insulin resistance. However,
this susceptibility might not be due to aging per se, since
adiposity was also increased in the older mice. As our
study design does not permit to discriminate between the
effects of aging and adiposity on skeletal muscle metabo-
lism and the development of insulin resistance, future
experiments should be directed at conducting weight loss
(food restriction) studies or exercise studies to determine
if these ‘aging’ effects are prevented or mitigated by
controlling adiposity. Nevertheless, as aging and increased
adiposity co-associate our ﬁndings likely reﬂect the major-
ity of middle-aged humans in the western world who are at
risk of developing insulin resistance.
Although intramuscular lipid accumulation associated
with aging did not appear to result from mitochondrial
dysfunction, we do show a signiﬁcant twofold increase in
CD36 protein expression in skeletal muscle of high-fat fed
middle-aged mice compared to low-fat fed middle-aged
mice (Fig. 3L), suggesting fatty acid transport into muscle
exceeded the capacity for their oxidation. Although it is
unknown what caused increased CD36 expression in our
study, it may have resulted from high levels of plasma
glucose levels that have been shown to regulate CD36
expression through both transcriptional and/or transla-
tional mechanisms in rodents and humans (40,41). To
determine whether reduced fatty acid transport and me-
tabolism could rescue the high-fat diet-induced phenotype,
we utilized the CD36 KO mouse (19). Consistent with our
prediction, CD36 deﬁciency prevented the decline in met-
abolic rate and energy expenditure in middle-aged mice
fed a high-fat diet as compared to age-matched wild-type
mice (Fig. 4E and 4F). Since food intake was similar
between groups (Fig. 4C), we propose that increased
energy expenditure in high-fat fed middle-aged CD36 KO
mice contributes to their protection against diet-induced
obesity (Fig. 4B).
The blunted decline in metabolic rate in the middle-aged
CD36 KO mice fed a high-fat diet (Fig. 4E and 4F) was
accompanied by alterations in muscle concentrations of
several metabolic intermediates (Fig. 5A–5C; Supplemen-
tal Fig. 1), but no improvement in AMPK and ACC phos-
phorylation (Fig. 5D and 5E, respectively). The impact of
the diet on muscle metabolites in this study differed to
some extent as compared to a previous report (14) in
which tissue specimens were harvested from younger
animals in the fed state. Herein, tissues were collected
after an overnight fast because we sought to evaluate a
state of heightened fatty acid oxidation. Under these
conditions, high-fat feeding lowered several long-chain
acylcarnitines but increased LCOH acylcarnitines. The
drop in long-chain acylcarnitines could reﬂect decreased
fatty acid availability, lower CPT1 activity or increased
long-chain acyl CoA ﬂux through LCAD. Several lines of
evidence support the latter possibility. First, the high-fat
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muscle. Second, of the two major products of CPT1
(palmitoylcarnitine (C16) and oleylcarnitine (C18:1), only
the unsaturated species was reduced by the diet (Fig. 5A),
suggesting upregulation of the isomerase enzyme that
catalyzes conversion of the double bond (42). Third, the
generalized rise in LCOH species (Fig. 5B) along with the
high LCOH/long-chain ratio (Fig. 5C) in response to
chronic lipid exposure suggest a shift in ﬂux limitation
from the earlier to later steps in -oxidation. Lastly, the
diet resulted in a robust drop in whole body RER, indica-
tive of a systemic increase in fat oxidation. Notably, CD36
deﬁciency altered baseline levels of several muscle metab-
olites, and in general, tended to mitigate diet-induced
changes in several acylcarnitine and amino acid species.
This apparent resistance to diet-induced metabolic pertur-
bations in the CD36 KO mice might be directly related to a
reduction in fat delivery and/or secondary to enhanced
energy expenditure and insulin sensitivity. Although fur-
ther work is necessary to fully understand the implications
of these results, it is clear that loss of CD36 has a global
impact on muscle fuel metabolism. In addition, it is
possible that other organs such as adipose tissue, liver and
brain (43,44) are also involved in maintaining a high level
of energy expenditure in the middle-aged CD36 KO mice.
Overall, ablation of CD36 was associated with an im-
provement in whole-body glucose utilization and insulin
sensitivity (Fig. 5J–5M) in mice fed a high-fat diet. Al-
though the mechanisms responsible for this are not
known, excessive intramuscular lipid accumulation in-
duced by high-fat feeding was prevented in skeletal muscle
of middle-aged CD36 KO mice (Fig. 5G and 5H). Whereas
elevated intramuscular triglyceride levels were not asso-
ciated with insulin resistance in young mice (Fig. 2J–2K),
preventing the more dramatic age- and diet-induced accu-
mulation of intramuscular triglyceride and long-chain acyl
CoA levels in middle-aged CD36 KO mice correlated with
improved whole-body insulin sensitivity. Although there is
ample evidence indicating that CD36 ablation signiﬁcantly
reduces skeletal muscle fatty acid uptake (31,32), it is also
possible that the effects that we report using the CD36 KO
mice are secondary to changes in fatty acid metabolism.
Notwithstanding this later possibility, our data demon-
strate that limiting CD36-mediated skeletal muscle fatty
acid transport guards against whole-body and muscle
insulin resistance in middle-aged mice fed a high-fat diet.
This ﬁnding suggests a potential therapeutic strategy for
combating metabolic disease in the face of age-related
abnormalities.
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